Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
HOXB5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
ATP1B3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINC01069 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
CTNS - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TTC7A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
ARHGAP32 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KCNH2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FKBP15 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GATA3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CHST7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TFRC - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SUGP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINC00927 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SNAP47 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HSPB6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MIOS - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on